Gemphire to Present at the LD Micro Invitational and the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:08 pm UTC| Business
LIVONIA, Mich., June 01, 2017 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including...
Gemphire to Present at the LD Micro Invitational and the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:08 pm UTC| Business
LIVONIA, Mich., June 01, 2017 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including...
Gemphire to Present at the LD Micro Invitational and the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:08 pm UTC| Business
LIVONIA, Mich., June 01, 2017 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including...
Gemphire to Present at the LD Micro Invitational and the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:08 pm UTC| Business
LIVONIA, Mich., June 01, 2017 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including...
Gemphire to Present at the LD Micro Invitational and the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:08 pm UTC| Business
LIVONIA, Mich., June 01, 2017 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including...
Gemphire to Present at the LD Micro Invitational and the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:08 pm UTC| Business
LIVONIA, Mich., June 01, 2017 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including...
Gemphire to Present at the LD Micro Invitational and the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:08 pm UTC| Business
LIVONIA, Mich., June 01, 2017 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including...
Australia’s Corporate Regulator Urges Pension Funds to Boost Technology Investment as Industry Grows